中国康复理论与实践
中國康複理論與實踐
중국강복이론여실천
Chinese Journal of Rehabilitation Theory and Practice
2015年
11期
1256-1259
,共4页
于治华%王君%樊建华%高红华%高连波
于治華%王君%樊建華%高紅華%高連波
우치화%왕군%번건화%고홍화%고련파
急性脑梗死%动脉粥样硬化%巨噬细胞移动抑制因子%基质金属蛋白酶-9%超敏C-反应蛋白%美国国立卫生研究院卒中量表
急性腦梗死%動脈粥樣硬化%巨噬細胞移動抑製因子%基質金屬蛋白酶-9%超敏C-反應蛋白%美國國立衛生研究院卒中量錶
급성뇌경사%동맥죽양경화%거서세포이동억제인자%기질금속단백매-9%초민C-반응단백%미국국립위생연구원졸중량표
acute cerebral infarction%atherosclerosis%macrophage migration inhibitory factor%matrix metalloproteinase-9%hypersensi-tive C-reactive protein%National Institute of Health Stroke Scale
目的:探讨急性脑梗死患者血清巨噬细胞移动抑制因子(MIF)、基质金属蛋白酶-9(MMP-9)、超敏C-反应蛋白(hs-CRP)水平与病情严重程度的相关性。方法急性脑梗死患者101例根据美国国立卫生研究院卒中量表(NIHSS)评分分为轻型脑梗死组(A组,NIHSS评分<4分,n=38)、中型脑梗死组(B组,NIHSS评分4~15分,n=36)和重型脑梗死组(C组,NIHSS评分>15分,n=27);同期住院44例有动脉粥样硬化危险因素非急性脑梗死患者为对照组(D组)。酶联免疫吸附法测定血清中MIF、MMP-9水平,免疫散射比浊法检测hs-CRP水平。结果各组间MIF、MMP-9及hs-CRP水平从高到低依次为C组、B组、A组、D组(P<0.05)。MIF与MMP-9(r=0.301, P<0.01)和hs-CRP (r=0.309, P<0.001)呈正相关。结论急性脑梗死患者血清MIF、MMP-9、hs-CRP水平升高,可能预测动脉粥样硬化斑块稳定性。
目的:探討急性腦梗死患者血清巨噬細胞移動抑製因子(MIF)、基質金屬蛋白酶-9(MMP-9)、超敏C-反應蛋白(hs-CRP)水平與病情嚴重程度的相關性。方法急性腦梗死患者101例根據美國國立衛生研究院卒中量錶(NIHSS)評分分為輕型腦梗死組(A組,NIHSS評分<4分,n=38)、中型腦梗死組(B組,NIHSS評分4~15分,n=36)和重型腦梗死組(C組,NIHSS評分>15分,n=27);同期住院44例有動脈粥樣硬化危險因素非急性腦梗死患者為對照組(D組)。酶聯免疫吸附法測定血清中MIF、MMP-9水平,免疫散射比濁法檢測hs-CRP水平。結果各組間MIF、MMP-9及hs-CRP水平從高到低依次為C組、B組、A組、D組(P<0.05)。MIF與MMP-9(r=0.301, P<0.01)和hs-CRP (r=0.309, P<0.001)呈正相關。結論急性腦梗死患者血清MIF、MMP-9、hs-CRP水平升高,可能預測動脈粥樣硬化斑塊穩定性。
목적:탐토급성뇌경사환자혈청거서세포이동억제인자(MIF)、기질금속단백매-9(MMP-9)、초민C-반응단백(hs-CRP)수평여병정엄중정도적상관성。방법급성뇌경사환자101례근거미국국립위생연구원졸중량표(NIHSS)평분분위경형뇌경사조(A조,NIHSS평분<4분,n=38)、중형뇌경사조(B조,NIHSS평분4~15분,n=36)화중형뇌경사조(C조,NIHSS평분>15분,n=27);동기주원44례유동맥죽양경화위험인소비급성뇌경사환자위대조조(D조)。매련면역흡부법측정혈청중MIF、MMP-9수평,면역산사비탁법검측hs-CRP수평。결과각조간MIF、MMP-9급hs-CRP수평종고도저의차위C조、B조、A조、D조(P<0.05)。MIF여MMP-9(r=0.301, P<0.01)화hs-CRP (r=0.309, P<0.001)정정상관。결론급성뇌경사환자혈청MIF、MMP-9、hs-CRP수평승고,가능예측동맥죽양경화반괴은정성。
Objective To investigate the relationship of serum levels of macrophage migration inhibitory factor (MIF), matrix metallo-proteinase-9 (MMP-9), hypersensitive C-reactive protein (hs-CRP) with the severity of acute cerebral infarction (ACI). Methods 101 pa-tients with ACI were envolved and divided into 3 groups according to the scores of National Institute of Health Stroke Scale (NIHSS):mild group (group A, n=38, NIHSS score<4), moderate group (group B, n=36, NIHSS score 4-15) and severe group (group C, n=27, NIHSS score>15). Meanwhile, 44 non-ACI inpatients with atherosclerosis were included as control group (group D). Their serum MIF and MMP-9 were detected with ELISA, and hs-CRP with immunoturbidimety. Results The levels of serum MIF, MMP-9 and hs-CRP ranged from more to less as groups C, B, A and D (P<0.05). There was positive correlation of MIF with MMP-9 (r=0.301, P<0.01) and hs-CRP (r=0.309, P<0.001). Conclusion Serum MIF, MMP-9 and hs-CRP levels increased with the severity in ACI patients, which may be prediction of athero-sclerotic plaque instability.